AN2 Therapeutics, Inc. (ANTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
ANTX price, last 12 months
Key stats
- Previous close
- $4.95
- Open
- $4.99
- Day range
- $4.82 – $5.42
- 52-week range
- $1.00 – $7.19
- Volume
- 786.2K
- Avg volume (20 days)
- 328.8K
- Market cap
- $172.6M
Performance
Technicals and fundamentals
About AN2 Therapeutics, Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $172.6M